S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for Its First Phase 3 Clinical Trial of TG-1101 (ublituximab) in Combination With Imbruvica(R) (ibrutinib) for Patients With Previously Treated Chronic Lymphocytic Leukemia|
|TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting|
|TVI Announces Members of Project Advisory Group|
|TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update|
|TG Therapeutics Announces Novel "Chemo-free" Triple Therapy Combination Clinical Study for Patients With Chronic Lymphocytic Leukemia and Other B-cell Malignancies|
|TG Therapeutics Announces Exercise of License Option for Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202|
|UPDATE -- TG Therapeutics, Inc. to Present at the 16th Annual Rodman & Renshaw Global Investment Conference|
|TG Therapeutics, Inc. to Present at the 16th Annual Rodman & Renshaw Global Investment Conference|
|TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2014 Financial Results and Business Update|
|Canaccord Genuity Group Inc. reports second quarter fiscal 2015 results and adjusted net income improvement of 208% (2014/11/5)|
Click above to view more mutual fund data and stats for tgs - Tiger Resources Ltd.